Search Results - Letters, Andrew*
-
1
-
2
-
3
-
4
Reply to Andrew J. Vickers’ Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging–visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003
Published in European urologyGet full text
Article -
5
-
6
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner’s Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63–71
Published in European urologyGet full text
Article -
7
Reply to Emily Vertosick and Andrew Vickers’ Letter to the Editor re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer after Radical Prostatectomy: Results of a Match-Controlled Multi-institutional Analysis. Eur Urol 2012;62:472–87
Published in European urologyGet full text
Article -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast’s Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304–6. Prebiopsy MRI: Through the Looking Glass
Published in European urologyGet full text
Article -
19
Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan’s Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304–6
Published in European urologyGet full text
Article -
20